Circulating interleukin-18 (IL-18) is a predictor of response to gemcitabine based chemotherapy in patients with pancreatic adenocarcinoma.


Usul A. , KARABULUT M., KARABULUT S., ALıS H., GONENC M., DAGOGLU N., ...Daha Fazla

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, cilt.23, ss.196-200, 2017 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 23
  • Basım Tarihi: 2017
  • Doi Numarası: 10.1016/j.jiac.2016.12.003
  • Dergi Adı: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
  • Sayfa Sayıları: ss.196-200